Stroke network performance during the first COVID-19 pandemic stage: A meta-analysis based on stroke network models

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:2997026 37 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Stroke network performance during the first COVID-19 pandemic stage: A meta-analysis based on stroke network models
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Background: The effect of the COVID pandemic on stroke network performance is unclear, particularly with consideration of drip&ship vs. mothership models. Aims: We systematically reviewed and meta-analyzed variations in stroke admissions, rate and timing of reperfusion treatments during the first wave COVID pandemic vs. the pre-pandemic timeframe depending on stroke network model adopted. Summary of findings: The systematic review followed registered protocol (PROSPERO-CRD42020211535), PRISMA and MOOSE guidelines. We searched MEDLINE, EMBASE, and CENTRAL until 9 October 2020 for studies reporting variations in ischemic stroke admissions, treatment rates, and timing in COVID (first wave) vs. control-period. Primary outcome was the weekly admission incidence rate ratio (IRR = admissions during COVID-period/admissions during control-period). Secondary outcomes were (i) changes in rate of reperfusion treatments and (ii) time metrics for pre- and in-hospital phase. Data were pooled using random-effects models, comparing mothership vs. drip&ship model. Overall, 29 studies were included in quantitative synthesis (n = 212,960). COVID-period was associated with a significant reduction in stroke admission rates (IRR = 0.69, 95%CI = 0.61–0.79), with higher relative presentation of large vessel occlusion (risk ratio (RR) = 1.62, 95% confidence interval (CI) = 1.24–2.12). Proportions of patients treated with endovascular treatment increased (RR = 1.14, 95%CI = 1.02–1.28). Intravenous thrombolysis decreased overall (IRR = 0.72, 95%CI = 0.54–0.96) but not in the mothership model (IRR = 0.81, 95%CI = 0.43–1.52). Onset-to-door time was longer for the drip&ship in COVID-period compared to the control-period (+32 min, 95%CI = 0–64). Door-to-scan was longer in COVID-period (+5 min, 95%CI = 2–7). Door-to-needle and door-to-groin were similar in COVID-period and control-period. Conclusions: Despite a 35% drop in stroke admissions during the first pandemic wave, proportions of patients receiving reperfusion and time-metrics were not inferior to control-period. Mothership preserved the weekly rate of intravenous thrombolysis and the onset-to-door timing to pre-pandemic standards. © 2021 World Stroke Organization.
Έτος δημοσίευσης:
2021
Συγγραφείς:
Romoli, M.
Eusebi, P.
Forlivesi, S.
Gentile, M.
Giammello, F.
Piccolo, L.
Giannandrea, D.
Vidale, S.
Longoni, M.
Paolucci, M.
Hsiao, J.
Sayles, E.
Yeo, L.L.L.
Kristoffersen, E.S.
Chamorro, A.
Jiao, L.
Khatri, P.
Tsivgoulis, G.
Paciaroni, M.
Zini, A.
Περιοδικό:
International Journal of Stroke
Εκδότης:
SAGE Publications Inc.
Τόμος:
16
Αριθμός / τεύχος:
7
Σελίδες:
771-783
Λέξεις-κλειδιά:
blood clot lysis; blood vessel occlusion; cerebrovascular accident; clinical outcome; coronavirus disease 2019; door to groin tme; door to needle time; door to scan time; endovascular surgery; health care quality; hospital admission; human; incidence; ischemic stroke; meta analysis; pandemic; Review; systematic review; time factor; cerebrovascular accident; fibrinolytic therapy; hospitalization; pandemic; reperfusion; time to treatment, COVID-19; Hospitalization; Humans; Incidence; Pandemics; Reperfusion; Stroke; Thrombolytic Therapy; Time-to-Treatment
Επίσημο URL (Εκδότης):
DOI:
10.1177/17474930211041202
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.